LA
UTHR icon

LBP AM’s United Therapeutics UTHR Stock Holding History

LBP AM’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Sell
1,910
-10,182
-84% -$5.73M 0.01% 369
2026
Q1 		$7.17M Sell
12,092
-7,908
-40% -$3.94M 0.1% 177
2025
Q4 		$9.74M Buy
+20,000
New +$9.31M 0.11% 169
2024
Q3 		– Sell
-3,400
Closed -$1.08M – 413
2024
Q2 		$1.08M Sell
3,400
-830
-20% -$220K 0.04% 210
2024
Q1 		$972K Buy
+4,230
New +$955K 0.04% 238

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

LBP AM's UTHR Position: Q2 2026 in Review

LBP AM reduced its United Therapeutics (UTHR) stake by 84% in Q2 2026, selling an estimated $5.73M and leaving 1,910 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #369.

LBP AM first reported a position in UTHR in Q1 2024 and has held it in 5 quarters since. The position peaked at $9.74M in Q4 2025. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • LBP AM held 1,910 shares of United Therapeutics worth $1.03M as of Q2 2026.
  • LBP AM sold 10,182 United Therapeutics shares in Q2 2026, an estimated $5.73M.
  • United Therapeutics made up 0.01% of LBP AM's portfolio in Q2 2026, its #369 holding.
  • LBP AM first reported a position in United Therapeutics in Q1 2024 and has held it in 5 quarters since.
  • LBP AM's United Therapeutics position peaked at $9.74M in Q4 2025.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.